Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by thewolf4on Nov 13, 2017 7:43pm
266 Views
Post# 26955634

Insider Transactions

Insider TransactionsAccording to SEDI, insiders exercised a large number of rights on November 6. Most of the rights had exercise prices far above the current share price. Then, 1.9M shares were sold by insiders at a block price of $1.5089. The total volume on all indexes that day wasn't even 1.9M and the price was $1.40 not $1.50 that day. Is that just a mistake in the filing or is there an explanation for that? Also, why would all the insiders exercise rights at prices well above the current price only to sell them at a loss on the same day? 
Bullboard Posts